-
United States
- Call us: +213 / 3753998
- Afghanistan
- Albania
- Algeria
- Andorra
- Angola
- Argentina
- Armenia
- Australia
- Austria
- Azerbaijan
- Bahrain
- Bangladesh
- Barbados
- Belarus
- Belgium
- Belize
- Benin
- Bhutan
- Bolivia
- Bosnia and Herzegovina
- Brazil
- Brunei
- Bulgaria
- Cambodia
- Cameroon
- Canada
- Cape Verde
- Central African Republic
- Chad
- Chile
- China
- Comoros
- Costa Rica
- Croatia
- Cuba
- Cyprus
- Czech Republic
- Denmark
- Djibouti
- Ecuador
- El Salvador
- Equatorial Guinea
- Eritrea
- Estonia
- Ethiopia
- Fiji
- Finland
- France
- Gabon
- Gambia, The
- Georgia
- Germany
- Ghana
- Greece
- Grenada
- Guatemala
- Guyana
- Haiti
- Honduras
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kazakhstan
- Kenya
- Kiribati
- Korea, South
- Kuwait
- Latvia
- Lebanon
- Liberia
- Libya
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malawi
- Malaysia
- Maldives
- Mali
- Malta
- Marshall Islands
- Mauritania
- Mauritius
- Mexico
- Micronesia
- Moldova
- Monaco
- Morocco
- Mozambique
- Myanmar
- Nepa
- Netherlands
- New Zealand
- Nicaragua
- Niger
- Nigeria
- Norway
- Oman
- Pakistan
- Palau
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russia
- Saint Kitts and Nevis
- Samoa
- Sao Tome and Principe
- Senegal
- Seychelles
- Singapore
- Slovenia
- Solomon Islands
- Somalia
- South Africa
- Spain
- Sri Lanka
- Sudan
- Suriname
- Swaziland
- Sweden
- Switzerland
- Syria
- Taiwan
- Tajikistan
- Tanzania
- Thailand
- The Republic of Colombia
- Togo
- Tonga
- Tunisia
- Turkey
- Tuvalu
- Uganda
- Ukraine
- United Kingdom
- United States
- Uruguay
- Venezuela
- Vietnam
- Yemen
- Zambia
- Zimbabwe
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using FADD (Phospho-Ser194) Antibody. The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts from HeLa cells treated with Paclitaxel 1uM 60', using FADD (Phospho-Ser194) Antibody. The lane on the right is treated with the synthesized peptide
Product Profile
| Product Name | Rabbit anti-FADD (Phospho-Ser194) polyclonal antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | The antiserum was produced against synthesized peptide derived from human FADD around the phosphorylation site of Ser194. |
Key Feature
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | |
WB:1:500~1:1000 IHC:1:50~1:100 ELISA:1:1000 |
|
| Species Reactivity | |
| Concentration | 1 mg/ml |
| Purification | Affinity purified |
Target Information
| Gene Symbol | FADD |
|---|---|
| Gene Synonyms | FAS-associating death domain-containing protein Mediator of receptor induced toxicity MORT1 |
Database Links
| Entrez Gene | 8772 |
|---|---|
| Unigene | 86131 |
| OMIM | 602457 |
| SwissProt ID | Q13158 |
Application
-
Immunohistochemical
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using FADD (Phospho-Ser194) Antibody. The picture on the right is treated with the synthesized peptide.
-
Western blot
Western blot analysis of extracts from HeLa cells treated with Paclitaxel 1uM 60', using FADD (Phospho-Ser194) Antibody. The lane on the right is treated with the synthesized peptide
| Application Notes | WB:1:500~1:1000 IHC:1:50~1:100 ELISA:1:1000 |
|---|
Additional Information
| Form | Liquid |
|---|---|
| Storage Instructions | store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
- Related products
- FADD Antibody OM278425
- FADD Antibody OM278424
- Fadd Antibody OM278423
- Rabbit anti-FADD polyclonal antibody OM123861
- Rabbit anti-FADD (Phospho-Ser194) polyclonal antibody OM123858
-
- ASSAY KITS
-
- SERUM
2013 © Omnimabs , All Rights Reserved.